Guard Therapeutics International AB (publ)

OM:GUARD 株式レポート

時価総額:SEK 265.6m

Guard Therapeutics International 過去の業績

過去 基準チェック /06

Guard Therapeutics Internationalの収益は年平均-19.6%で減少しているが、Biotechs業界はgrowingで7.7%年平均の収益となった。

主要情報

-19.6%

収益成長率

18.5%

EPS成長率

Biotechs 業界の成長0.7%
収益成長率n/a
株主資本利益率-137.8%
ネット・マージンn/a
前回の決算情報30 Sep 2024

最近の業績更新

更新なし

Recent updates

We're Keeping An Eye On Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Nov 19
We're Keeping An Eye On Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Companies Like Guard Therapeutics International (STO:GUARD) Could Be Quite Risky

Apr 18
Companies Like Guard Therapeutics International (STO:GUARD) Could Be Quite Risky

Guard Therapeutics International (STO:GUARD) Will Have To Spend Its Cash Wisely

Jan 04
Guard Therapeutics International (STO:GUARD) Will Have To Spend Its Cash Wisely

Here's Why Guard Therapeutics International (STO:GUARD) Must Use Its Cash Wisely

Sep 20
Here's Why Guard Therapeutics International (STO:GUARD) Must Use Its Cash Wisely

Guard Therapeutics International (STO:GUARD) Is In A Good Position To Deliver On Growth Plans

Apr 06
Guard Therapeutics International (STO:GUARD) Is In A Good Position To Deliver On Growth Plans

We're Keeping An Eye On Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Sep 09
We're Keeping An Eye On Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Here's Why We're A Bit Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Situation

Feb 19
Here's Why We're A Bit Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Situation

We're Not Very Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Aug 17
We're Not Very Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Rate

Companies Like Guard Therapeutics International (STO:GUARD) Are In A Position To Invest In Growth

Apr 19
Companies Like Guard Therapeutics International (STO:GUARD) Are In A Position To Invest In Growth

Here's Why We're Watching Guard Therapeutics International's (STO:GUARD) Cash Burn Situation

Jan 04
Here's Why We're Watching Guard Therapeutics International's (STO:GUARD) Cash Burn Situation

収支内訳

Guard Therapeutics International の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

OM:GUARD 収益、費用、利益 ( )SEK Millions
日付収益収益G+A経費研究開発費
30 Sep 240-871079
30 Jun 240-79972
31 Mar 240-88982
31 Dec 230-1139106
30 Sep 230-1378131
30 Jun 230-1469139
31 Mar 230-1349126
31 Dec 220-1139105
30 Sep 220-95987
30 Jun 220-97790
31 Mar 220-88780
31 Dec 210-82675
30 Sep 210-69564
30 Jun 210-47542
31 Mar 210-44539
31 Dec 200-40535
30 Sep 200-43537
30 Jun 200-39533
31 Mar 200-41635
31 Dec 190-45738
30 Sep 190-731040
30 Jun 190-821170
31 Mar 190-861273
31 Dec 180-871274
30 Sep 180-611051
30 Jun 180-63954
31 Mar 180-671254
31 Dec 170-681255
30 Sep 170-721262
30 Jun 170-681457
31 Mar 170-611054
31 Dec 160-521045
30 Sep 160-431032
30 Jun 160-351026
31 Mar 160-32923
31 Dec 150-30823
30 Sep 150-23617
30 Jun 150-20515
31 Mar 150-15411
31 Dec 140-14410
30 Sep 142-1258
30 Jun 145-985
31 Mar 147-7112
31 Dec 138-5130

質の高い収益: GUARDは現在利益が出ていません。

利益率の向上: GUARDは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: GUARDは利益が出ておらず、過去 5 年間で損失は年間19.6%の割合で増加しています。

成長の加速: GUARDの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: GUARDは利益が出ていないため、過去 1 年間の収益成長をBiotechs業界 ( -18.2% ) と比較することは困難です。


株主資本利益率

高いROE: GUARDは現在利益が出ていないため、自己資本利益率 ( -137.79% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘